Johnson & Johnson Innovation, a division of Johnson & Johnson (NYSE:JNJ) (China) Investment Ltd., launched a 4,400-square-meter incubator for healthcare startups in Shanghai Thursday. The incubator “JLABS,” located in Shanghai’s Zhangjiang High-Tech Park, can accommodate about 50 startups and opened with 31 companies from a range of sectors including therapeutics, medical devices and medical technology.
The stock Earnings per share (EPS) and the diluted EPS are the profitability measures used in the fundamental analysis of companies. The figure of EPS only takes into account a Johnson & Johnson (NYSE:JNJ) common shares, whereas the very important diluted EPS take into account all the convertible securities such as convertible bonds/convertible preferred stock, which are changed into equity or common stock. Dilutive effects occur when the number of shares increases, for example, through a new issue. If a company issues more shares to shareholders and other investors, this increases the number of shares outstanding and decreases the company’s earnings per share. Ultimately, this can decrease the stock price.Johnson & Johnson (NYSE:JNJ) Diluted EPS is 5.40, whereas the EPS Estimate for next year is 9.15. The Annual EPS Growth of past 5 years is 3.10% and Johnson & Johnson (NYSE:JNJ) yearly performance is 14.53% and net profit margin is 18.00%.
Key Performance indicators for Johnson & Johnson (NYSE:JNJ), in last 4 months the performance of JNJ was -0.36% while its price to sale ratio is 4.58 and price to book ratio is 6.29. Company gross margin stands at 66.90% whereas its return on investment (ROI) is 17.00%.
On 28 June 2019, Johnson & Johnson (NYSE:JNJ), a Healthcare sector firm, traded 12.75 Million shares in last trading session and stock fell -1.00% with closing price of $139.28 per share. with Johnson & Johnson (NYSE:JNJ) traded 12.75 Million shares. The JNJ distance from 20 day simple moving average is 0.15% and distance from 50-Day simple moving average is 0.31%.The relative strength index for stock is 47.39 and Average true range of JNJ is 2.17.
Analyst’s mean target price for JNJ is $149.17 while analysts mean recommendation is 2.30. The Stock value has moved between $120.07 – 149.76 in last one year. JNJ market capitalization is 373539.21 with beta of 0.71. Company has 0.07% insider ownership.
Johnson & Johnson (NYSE:JNJ) is under coverage by number of analysts. Stock has got OUTPERFORM rating from 5 of Thomson Reuters analysts, 8 given HOLD rating to the stock and 0 given UNDERPERFORM rating. Buy rating has been given by 5 analysts to the company stock.